English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA late summer increase in COVID-19-related hospitalizations and the emergence of new coronavirus variants raises concerns about how best to counter infection and who should receive the newly-approved vaccines.
Tag: Booster
The longer the bootcamp, the better the antibodies
LJI research shows that a “slow delivery, escalating dose” vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
UCLA leads CDC-funded study on effectiveness of vaccines, boosters in ‘next phase’ of COVID
The David Geffen School of Medicine at UCLA has been awarded a $13.6 million grant from the Centers for Disease Control and Prevention to continue to study the effectiveness of COVID-19 vaccines and the long-term impact of infection among U.S. health care workers. The new yearlong grant project follows the 2020–21 Preventing Emerging Infections Through Vaccine Effectiveness Testing study, or PREVENT I, which was among the first to demonstrate the real-world benefit of mRNA vaccines in preventing symptomatic infection following their authorization by the Food and Drug Administration.
Patients with Lupus Benefit from COVID-19 Vaccine Booster
People with systemic lupus erythematosus, or SLE, who received a “booster” dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent “breakthrough” COVID-19 infection, a new study shows.
Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine
Most patients in the study mounted immune responses after a booster dose, and no patient with antibody responses died from COVID-19.
FAU Expert Answers Questions about Boosters, Vaccines for Children Ages 5-11
Joanna Drowos, D.O., M.P.H., M.B.A., FAU Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 boosters and vaccines for children ages 5 to 11.